Ohio HB966 mandates a study on the prevalence of cholestatic liver disorders among women aged 35-45 in the Ohio Medicaid program.

Ohio HB966 directs the Department of Health to conduct a one-year study on the prevalence of cholestatic liver disorders among women aged 35-45 enrolled in the Ohio Medicaid program. The study will collect data on demographics, genetic predispositions, pre-existing conditions, and lifestyle factors. It will also analyze the number of high-risk women who do not follow through with medical referrals or treatment recommendations.

Ohio HB966 mandates a study on the prevalence of cholestatic liver disorders among women aged 35-45 in the Ohio Medicaid program.

Ohio HB966 directs the Department of Health to conduct a one-year study on the prevalence of cholestatic liver disorders among women aged 35-45 enrolled in the Ohio Medicaid program. The study will collect data on demographics, genetic predispositions, pre-existing conditions, and lifestyle factors. It will also analyze the number of high-risk women who do not follow through with medical referrals or treatment recommendations.